MYL9 and colorectal carcinoma: The expression of MYL9 and the OS, disease-free survival (DFS), disease-specific survival (DSS), relapse-free survival (RFS), and progression-free survival (PFS) of patients with CRC were analyzed to evaluate the prognostic potential of MYL9.